Well, I cheer them on regularly but try to stay balanced, and, I agree an imaging biomarker as well as an assay biomarker would be a tremendous win for NWBO and management of GBM. Any connections between NWBO and FDA are good. I hope FDA is monitoring the trial closely though I know it is the decision of the company to stop it if the result is positive. And, I think they have such a data need that they are trying to maximize the data mine with this trial. It is the pivotal trial for GBM approval but it is truly the pivotal for the company.
News 
Market Data 
Discover 
AI
